In deliveryUnited KingdomGoods£45,077,163
Transitional Drugs 5
- Published
- Published 6 October 2025
- Deadline
- Closed 17 November 2025
Overview
The provision of Drugs that have recently lost exclusivity
Key details
- Country
- United Kingdom
- Status
- In delivery
- Category
- Goods
- Estimated value
- £45,077,163
- Procedure
- Open
- SME suitable
- Yes
- Published
- 6 October 2025
- Questions by
- 14 November 2025
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- £5,577,339
- Award date
- 25 November 2025
- Contract period
- 1 January 2026 → 31 December 2027
- Janssen Ltd
- Mercury Pharmaceuticals Ltd
- Teva UK Ltd
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
29 January 2026
View notice ↗Contract
8 December 2025
View notice ↗Contract Notice
16 October 2025
View notice ↗Prior Information Notice
6 October 2025
View notice ↗
Contracting authority
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
BuyerCardiff, United Kingdom
GB-NHS: RQF
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.